NCT00669006

Brief Summary

To establish the infrastructure for a national neuropathic pain database. To determine the longterm outcome of the management of chronic neuropathic pain including pain relief, disability, and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
789

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

April 28, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 29, 2008

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
8.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2020

Completed
Last Updated

October 19, 2021

Status Verified

February 1, 2021

Enrollment Period

3.8 years

First QC Date

April 28, 2008

Last Update Submit

October 18, 2021

Conditions

Neuropathic Pain

Keywords

neuropathic paindatabaseprospectivenational

Outcome Measures

Primary Outcomes (1)

  • To establish the infrastructure for a national Neuropathic Pain Database.

    To establish the infrastructure for a National Neuropathic Pain Database, with a composite primary outcome measure in average pain intensity (based on average pain intensity of BPI) and reduction in disability (based on Interference Scale Score of BPI))

    2 years

Secondary Outcomes (1)

  • To determine the longterm outcome of the management of chronic neuropathic pain including pain relief, disability and quality of life.

    2 years

Study Arms (1)

1

New patients with a diagnosis of Neuropathic Pain

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

New patients referred to the outpatient pain clinic with a diagnosis of Neuropathic Pain.

You may qualify if:

  • Primarily Neuropathic Pain
  • Able to give informed consent
  • Estimated Life Expectancy of 2 years

You may not qualify if:

  • Not primarily neuropathic pain
  • Declined participation- too much traveling
  • Declined participation- Unknown
  • Declined participation- Other, specify
  • Considered unreliable- personality disorder
  • Considered unreliable- cognitive impairment
  • Considered unreliable- substance abuse
  • Considered unreliable- Other
  • Language barrier
  • Exceeded quarterly quota
  • Presentation with progressive or recurrent cancer, fibromyalgia, perineal pain of unknown etiology
  • Other, specify

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre- St. Joseph's Health Care

London, Ontario, N6A 4V2, Canada

Location

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dwight Moulin, MD

    London Health Sciences Centre- St. Joseph's Health Care

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2008

First Posted

April 29, 2008

Study Start

April 1, 2008

Primary Completion

February 1, 2012

Study Completion

February 24, 2020

Last Updated

October 19, 2021

Record last verified: 2021-02

Locations

CA(1)